Neuland Laboratories Financial Results

BSE Code: 524558NSE Symbol:NEULANDLABISIN: INE794A01010

16909 -289(-1.68)

Open (Rs) 17000

Close (Rs) 17198

High (Rs) 17097

Low (Rs) 16705

Face Value10

Market Capital (Cr.)21694.25

Daily Volume36516

Life Time High19747

Life Time Low61.07

52 Week High19747

52 Week Low11500

Results

Consolidated
IN CRMAR 2026MAR 2025MAR 2024MAR 2023MAR 2022MAR 2021
Net Sales2,022.991,476.841,558.581,191.20951.08936.91
Total Expenditure1,448.491,153.581,095.99919.36808.46790.10
PBIDT (Excl OI)574.50323.26462.59271.84142.62146.82
Other Income30.1720.5112.549.752.0816.10
Operating Profit604.67343.77475.13281.59144.70162.91
Interest23.958.3014.0013.0713.5017.90
Exceptional Items0.0076.400.000.000.000.00
PBDT580.72411.88461.14268.52131.20145.02
Depreciation91.7465.5559.7052.7849.0439.68
Profit Before Tax488.98346.33401.44215.7582.16105.33
Tax124.9886.22101.3652.2318.3424.70
Provisions and contingencies0.000.000.000.000.000.00
Profit After Tax364.00260.11300.08163.5263.8280.63
Extraordinary Items0.000.000.000.000.000.00
Prior Period Expenses0.000.000.000.000.000.00
Other Adjustments0.000.000.000.000.000.00
Net Profit364.00260.11300.08163.5263.8280.63
Equity Capital12.9012.9012.9012.9012.9012.90
Face Value (IN RS)10.0010.0010.0010.0010.0010.00
Reserves1,860.731,511.071,268.97980.36826.76772.72
Basic Eps After Extraordinary Items282.17201.63232.60126.7549.4762.50
Basic Eps Before Extraordinary Items282.17201.63232.60126.7549.4762.50
No of Public Share Holdings0.000.000.000.000.000.00
% of Public Share Holdings0.000.000.000.000.000.00
PBIDTM% (Excl OI)28.4021.8929.6822.8215.0015.67
PBIDTM%29.8923.2830.4823.6415.2117.39
PBDTM%28.7127.8929.5922.5413.8015.48
PBTM%24.1723.4525.7618.118.6411.24
PATM%17.9917.6119.2513.736.718.61

FAQs

What are the Net Sales of Neuland Laboratories in the financial year 2026?

For FY 2026, Neuland Laboratories recorded Net Sales of 2022.99 crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

What is the Operating Profit of Neuland Laboratories in 2026?

The Operating Profit of Neuland Laboratories for FY 2026 is 604.67 crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

What is the Profit Before Tax (PBT) of Neuland Laboratories in 2026?

In FY 2026, Neuland Laboratories posted a Profit Before Tax of 488.98 croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

What is the Net Profit of Neuland Laboratories for 2026?

Neuland Laboratories recorded a Net Profit of 364.00 crores in FY 2026. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

What is the Face Value of Neuland Laboratories?

The Face Value of Neuland Laboratories shares is 10.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

What is the PAT Margin (PATM%) of Neuland Laboratories in 2026?

In FY 2026, the PAT Margin of Neuland Laboratories is 17.99 %. This metric provides insights into the company's efficiency in generating profits after paying taxes.

How to open a Demat Account with Anand Rathi to invest in Neuland Laboratories?

Open a Demat Account with Anand Rathi using the following steps:

1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Neuland Laboratories using our TradeMobi App or Web Trading Platform.